| Literature DB >> 34975860 |
Po-Tsang Lee1, Fernando Y Yamamoto2, Chen-Fei Low3, Jiun-Yan Loh4, Chou-Min Chong5.
Abstract
The gastrointestinal immune system plays an important role in immune homeostasis regulation. It regulates the symbiotic host-microbiome interactions by training and developing the host's innate and adaptive immunity. This interaction plays a vital role in host defence mechanisms and at the same time, balancing the endogenous perturbations of the host immune homeostasis. The fish gastrointestinal immune system is armed with intricate diffused gut-associated lymphoid tissues (GALTs) that establish tolerance toward the enormous commensal gut microbiome while preserving immune responses against the intrusion of enteric pathogens. A comprehensive understanding of the intestinal immune system is a prerequisite for developing an oral vaccine and immunostimulants in aquaculture, particularly in cultured fish species. In this review, we outline the remarkable features of gut immunity and the essential components of gut-associated lymphoid tissue. The mechanistic principles underlying the antigen absorption and uptake through the intestinal epithelial, and the subsequent immune activation through a series of molecular events are reviewed. The emphasis is on the significance of gut immunity in oral administration of immunoprophylactics, and the different potential adjuvants that circumvent intestinal immune tolerance. Comprehension of the intestinal immune system is pivotal for developing effective fish vaccines that can be delivered orally, which is less labour-intensive and could improve fish health and facilitate disease management in the aquaculture industry.Entities:
Keywords: GALT; gut immunity; immune tolerance; immunoprophylaxis; immunostimulants
Mesh:
Substances:
Year: 2021 PMID: 34975860 PMCID: PMC8716388 DOI: 10.3389/fimmu.2021.773193
Source DB: PubMed Journal: Front Immunol ISSN: 1664-3224 Impact factor: 7.561
Figure 1Gut-associated lymphoid tissues (GALT) of finfish. Fish gut possesses diffusely organized GALTs that comprise two main leukocyte populations. Firstly, intraepithelial leukocytes, which mostly consisted of IgM+ B-cells, cytotoxic T-cells, and macrophages. Secondly, the lamina propria leukocytes, which are consisting of lymphocytes, macrophages, granulocytes and dendritic-like cells. Subpopulations have been reported in teleost cytotoxic T-cells, macrophages, and helper T-cells.
Figure 2Antigen uptake in the gut. Their mechanisms of transcellular transport for exogenous antigens across teleost epithelial barriers have been described, namely fluid-phase uptake of soluble antigens by enterocytes via non-specific pinocytosis in carp and rainbow trout; solid-phase uptake of small solid antigens (<0.5 μm) by receptor-mediated endocytosis, and phagocytosis of larger particulate antigens. It has been proposed that the internalized antigens are processed in the endosome by merging with lysosomes containing enzymes, followed by systemic vascular release and transfer of the processed antigens to the intraepithelial or lamina propria antigen-presenting cells, viz. macrophages, some fish enterocytes expressed MHC-IIβ, which indicates that this cell might directly be serving as an antigen-presenting cell to activate the adaptive cells (35).
Orally administrated herbs having modulatory activity on the gut immune system.
| Source/form | Fish species/Body weight (g) | Doses | Duration | Results | Resistance to pathogen | Reference |
|---|---|---|---|---|---|---|
|
|
| 0-2% | 8 weeks | Intestine: | N.A. | ( |
|
|
| 0-2% | 6 weeks | Intestine: | N.A. | ( |
|
|
| 0-20% | 45 days | Intestine: |
| ( |
|
|
| 0-15 g/kg | 8 weeks | Intestine: | N.A. | ( |
|
|
| 0-2% | 8 weeks | Intestine: | N.A. | ( |
|
|
| 0-2% | 8 weeks | Intestine: | N.A. | ( |
|
|
| 0-10 g/kg | 8 weeks | Intestine: | N.A. | ( |
|
|
| 0-10 g/kg | 8 weeks | Intestine: |
| ( |
|
|
| 0-30% | 15 and 30 days | Intestine: | N.A. | ( |
|
|
| 0-1% | 21 days | Intestine: |
| ( |
|
|
| 0-1% | 84 days | Intestine: |
| ( |
|
|
| 0-1% | 8 weeks | Intestine: | N.A. | ( |
|
|
| 0-100 mg/kg | 70 days | Intestine: | N. A. | ( |
|
|
| 0-200 mg/kg | 60 days | Intestine: | N. A. | ( |
|
|
| 0-5% | 60 days | Intestine: |
| ( |
|
|
| 0-400 mg/kg | 8 weeks | Intestine: | N.A. | ( |
Oral vaccines and the feeding regimes.
| Source/form | Fish species/Body weight (g) | Doses | Feeding regime | Results | Resistance to pathogen | Reference |
|---|---|---|---|---|---|---|
|
|
| ~0.8-1.4 × 107
| Twice with a one-week interval | Intestine: |
| ( |
|
|
| 1.0 × 1010 CFU/g and 1.0 × 108 CFU/g | Vaccination was conducted on day 1–7 and day 15–21 | SUR ↑ after being challenged on day 60 post vaccination | VHSV | ( |
|
|
| 1.0 × 109 CFU/g diet | Vaccination was conducted at week 1 and week 5 | Intestine: | HIRRV | ( |
|
|
| 1 × 107 CFU/g feed | Vaccination was conducted for 1 week with a 1-week interval, repeating three times | Intestine: |
| ( |
|
|
| ~1.0 × 109 CFU/g feed | Vaccination was conducted on days 1–3 (prime vaccination), 18–20 (booster vaccination) and 34 (challenge) | Intestine: |
| ( |
|
|
| ~1.0 × 109 CFU/g feed | Vaccination was conducted on days 0–2 (prime vaccination), 14–15 (booster vaccination) and 34 (challenge) | Intestine: |
| ( |
|
|
| 1.0 × 109 CFU/g feed | Vaccination was conducted on day 1–3 and on day 18–20 | Intestine: |
| ( |
|
|
| 2.0 × 109 CFU/g feed | Vaccination was conducted on day 0–2 and on day 28–29 | Intestine: |
| ( |
|
|
| 2.0 × 109 CFU/g feed | Vaccination was conducted on day 1 and on day 32 | Intestine: |
| ( |
|
|
| 2 × 109 CFU/fish | Vaccination was conducted on days 1 and 32 | Intestine: | IPNV | ( |
|
|
| 200 μl of recombinant strains | Orogastric intubation was conducted on days 1, 2 and 3, and boost on days 31, 32, and 33 | Intestine: | IPNV | ( |
|
|
| 5.2 1010 CFU/g feed | Vaccination was conducted on day 1-3, day 14-16 (booster vaccination) and day 28-30 (booster vaccination) | SUR ↑ after being challenged on day 15 after the second booster | CyHV3 | ( |
|
|
| 1.0 × 1010 spores/fish | Vaccination was conducted on day 1 and day 8 | SUR ↑ after being challenged on day 14 after the boost immunization | GCRV | ( |
|
|
| 2.3 × 1011 spores/fish/day, amount to 1 × 10−3 μg/g (protein/fish) | Vaccination was conducted daily for 8 weeks | Intestine: | GCRV | ( |
|
|
| 109 CFU/100 μL/fish | Vaccination was conducted once on week 0 and once on week 3 | Intestine: |
| ( |
| Yeast expressing the OmpG and Omp48 of |
| 1.5 × 108 heat-killed yeast cells/g meal powder | Vaccination was conducted daily for 4 weeks | SUR ↑ after being challenged on day 28 |
| ( |
|
|
| 1.6 × 109 CFU yeast in 300 μL PBS | Vaccination was conducted 3 times at a 2-week interval | SUR ↑ after being challenged at four weeks post the third immunization | CyHV-3 | ( |
| Rootless duckweed (Wolffia) expresses LamB from |
| N. A. | Vaccination was conducted for 60 days from month 0-2 and boost for 30 days on month 3-4 | SUR ↑ after being challenged six weeks post-vaccination (booster) |
| ( |
| Tobacco leaves express RGNNV- capsid protein |
| 200 μg/fish | Vaccination was conducted once a day for five consecutive days | SUR ↑ after being challenged on day 21 after immunization | RGNNV | ( |
|
|
| 1010 CFU/g diet | Vaccination was conducted 3 consecutive days and a boost at day 14 | SUR ↑ after being challenged at 30 days post vaccination | NNV | ( |
| Tobacco expressing the capsid protein of NNV |
| 5 µg or 10 µg plant-derived recombinant coat protein | Vaccination was conducted every Monday at 2-week intervals for a total of 4 times | SUR ↑ after being challenged at six days after the final immunization | NNV | ( |
| AA | acetic acid |
| AHA1 |
|
| AJC | apical junctional complex |
| ARG | arginase |
| BA | butyric acid |
| C3 | Complement 3 |
| C4 | Complement 4 |
| CAT | catalase |
| CD | cluster of differentiation |
| CFU | colony forming unit |
| CK6 | Chemokine 6 |
| COX | cyclooxygenase |
| CSF1R | colony-stimulating factor 1 receptor |
| CuZnSOD | copper zinc superoxide dismutase |
| CyHV-3 | Cyprinid Herpesvirus 3 |
| DI | distal intestine |
| flaB | flagellin B |
| FlgD | flagellar hook protein D |
| GALT | gut-associted lymphoid tissues |
| GCRV | grass carp reovirus |
| GPx | glutathione peroxidase |
| GR | glutathione reductase |
| GST | glutathione S-transferases |
| HEP | hepcidin |
| HIRRV | Hirame novirhabdovirus |
| HSP | heat shock protein |
| IEL | intraepithelial lymphocyte |
| IFN | interferon |
| Ig | immunoglobulin |
| IL | interleukin |
| ILI | intestinal length index |
| InL | intestinal length |
| iNOS | inducible nitric oxide synthase |
| IPNV | Infectious pancreatic necrosis virus |
| ISI | intestinal somatic index |
| IW | intestinal weight |
| JAM-A | junctional adhesion molecule-A |
| Keap1 | Kelch-like- ECH-associated protein 1 |
| Lamb | Lambda B |
| LPS | lipopolysaccharides |
| LYZ | lysozyme |
| MDA | malondialdehyde |
| MHC | major histocompatibility complex |
| MI | middle intestine |
| MLCK | myosin light chain kinase |
| MV | microvillus |
| N.A. | Not available |
| NFκB | nuclear factor kappa B |
| NMII | non-muscle myosin II |
| NNV | Nerve necrosis virus |
| Nrf2 | nuclear factor erythroid 2–related factor 2 |
| OC | occluding |
| Omp | outer membrane protein |
| ORF131 | open reading frame 131 |
| PA | propionic acid |
| PBS | phosphate buffered saline |
| PP20 | prickly pear fruit peel-supplemented group (20%) |
| PrI | proximal intestine |
| RGNNV | red-spotted grouper nervous necrosis virus |
| RhoA | a small Rho GTPase protein |
| ROCK | the Rho associated protein kinase |
| SAA | serum amyloid A |
| SCFA | short chain fatty acids |
| Sip | surface immunogenic protein |
| SOD | superoxide dismutase |
| SUR | survival rate |
| T-AOC | total antioxidant capacity |
| T-bet | T-box expressed in T cells |
| TCR-β | T-cell receptor β chain |
| TGF | transforming growth factor |
| TJ | tight junction |
| TLR | toll-like receptor |
| TLR5M | membrane form of TLR5 |
| TNF | tumor necrosis factor |
| TOR | target of rapamycin |
| TP3 | Tilapia piscidin 3 |
| TRγδ | T-cell receptors of the γδ heterodimers |
| VHSV | viral haemorrhagic septicaemia virus |
| VP2 | viral protein 2 |
| ZO | zonula occludens |